Presence of SLA/LP-autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome);Nachweis von SLA/LP-autoantikörpern bei patienten mit primär biliärer zirrhose als marker für eine sekundäre autoimmune hepatitis (overlapsyndrom)

Deutsche Medizinische Wochenschrift

Volumn 126, Issue 16, 2001, Pages 450-456

  Kanzler, S ^a   Bozkurt, S ^a   Herkel, J ^a   Galle, P R ^a   Dienes, H P ^b   Lohse, A W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AUTOANTIBODY; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LIVER ANTIBODY; PANCREAS ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BILIARY CIRRHOSIS; CHOLESTASIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; IMMUNOGENETICS; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; RELAPSE;

ADULT; AGED; AUTOANTIBODIES; BIOPSY; BLOTTING, WESTERN; DATA INTERPRETATION, STATISTICAL; ENZYME TESTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW-UP STUDIES; GAMMA-GLOBULINS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; TIME FACTORS; TRANSAMINASES;

EID: 0035917644     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-12906     Document Type: Article

References (41)

1. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis
2. Establishment of standardized SLA/LP immunoassays. SLA/LP positive autoimmune hepatitis occurs wordwide
3. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
4. Chronic hepatitis. London: Churchill Livingstone
5. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy
6. Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis
7. Autoimmune hepatitis: Evolving concepts and treatment strategies
8. Frequency and nature of the variant syndromes of autoimmune liver disease
9. Development and prognosis of histologic cirrhosis in corticosteroid-treated HBsAg-negative chronic active hepatitis
10. Histologic features in autoimmune hepatitis
11. Susceptibility to autoimmune chronic active hepatitis: Human leucocyte antigens DR4 and A1-B8-DR3 are independent risk factors
12. The molecular genetics of autoimmune liver disease
13. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Corticoresistance and effective treatment by cyclosporine A
14. Primary biliary cirrhosis and mitochondrial autoantigens - Insights from molecular biology
15. Autoimmune cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases
16. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis
17. International autoimmune hepatitis group report, review of criteria for diagnosis of autoimmune hepatitis
18. Comparison of the clinical features and clinical course of antimitochondrial antibodypositive and -negative primary biliary cirrhosis
19. Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis
20. Duration of immunosuppressive therapy in autoimmune hepatitis (AIH)
21. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity
22. Autoimmune hepatitis
23. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: Liver-kidney microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue
24. Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: Results of a prospective double-blind trial
25. Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals
26. HLA associations with autoimmune type chronic active hepatitis: Identification of BS-DRw3 haplotype by family studies
27. Primary biliary cirrhosis: Current knowledge, perspectives, and future directions
28. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to anti-mitochondrial antibodies in inflammatory liver diseases
29. Characterisation of a new soubgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen
30. Two different subtypes of antimitochondrial antibodies are associated with primary biliary cirrhosis: Identification and characterization by radioimmunoassay and immunoblotting
31. Natural history of early primary biliary cirrhosis
32. Autoimmune hepatitis
33. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis
34. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: Hepatic improvement but greater bone loss
35. Hepatitis and cholestasis in a middle-aged woman
36. Ursodial for the long-term treatment of primary biliary cirrhosis
37. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
38. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients
39. Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis
40. Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
41. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: A 1-year randomized, placebo-controlled study